Product Datasheet
|
|
|
Product Description |
|
Product: |
Human Factor IXa-beta |
Catalog Number: |
HFIXA |
Product Page: |
https://www.mol-innov.com/products/ |
Description: |
Human Factor IXa is prepared from Human Factor IX by activation with Bovine Factor XIa. This Bovine Factor XIa is removed after activation. Complete activation is observed by SDS-PAGE. The Factor XIa activates Factor IX in a two-step reaction. In the first step, an internal Arg-Ala bond is cleaved, and in the second step, an Arg-Val bond is cleaved. The second cleavage leads to the liberation of an activation peptide from the NH2-terminal portion of the heavy chain to produce Factor IXa-beta. Factor IXa-alpha has only the second cleavage at the Arg-Val bond with about half the coagulant activity of Human Factor IXa-beta. Complete activation is observed by SDS-PAGE. This protein purity is determined by SDS-PAGE and shows total reduction upon incubation with 2-mercaptoethanol. Thaw rapidly in a 37C water bath without allowing protein to warm to 37C and immediately cool on ice. |
Recommended Storage: |
SAMPLE |
Minimum Shelf Life: |
418.00 |
Source: |
5.0 mg/ml |
Molecular Weight: |
Proteins |
Extinction Coefficient: |
45,000 |
Antigen: |
-70 C |
Target: |
Frozen liquid |
Target Molecular Weight: |
FACTOR IX |
Host: |
1349 |
Clonality: |
5 |
Isotype: |
Human plasma |
Clone: |
s |
Applications: |
Dry ice |
Cross-reactivity: |
3 years from delivery |
Concentration: |
440 |
Volume: |
1420 |
Titer: |
0.02M MES; 0.6M NaCl; pH 6.0 |
Buffer: |
SAMPLE |
Form: |
0.5 mg |
Preservative: |
0.1 ml |
|
Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
|
For in vitro laboratory use only |
|
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |